Shu-yun Ma
P.R. China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma.
Journal: Cell reports. Medicine
Published: April 07, 2022
Combination of PD-1 inhibitor with GVD (gemcitabine, vinorelbine, liposomal doxorubicin) versus GVD regimen as second-line therapy for relapsed/refractory classical Hodgkin lymphoma.
Journal: British journal of haematology
Published: June 27, 2021
A prognostic immune risk score for diffuse large B-cell lymphoma.
Journal: British journal of haematology
Published: December 22, 2020
BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T-cell lymphoblastic lymphoma.
Journal: Cancer communications (London, England)
Published: March 03, 2020
A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 25, 2019
Upfront autologous stem cell transplantation for untreated diffuse large B cell lymphoma patients in rituximab era: a systematic review and meta-analysis.
Journal: Annals of hematology
Published: October 29, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026